Please assess the completion status of the following clinical trial:

Trial Title: Confirmatory Study to Assess the V Needle in End-Stage Renal Disease Patients During In-Clinic Hemodialysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects with end-stage renal disease receiving chronic hemodialysis in a clinical setting.~2. Subjects must be able to receive hemodialysis with the Hemotek 15-gauge, 1 inch length V Needle, with 12 inch tubing.~3. Age greater than or equal to 22 years old at screening.~4. Vascular access via a mature arteriovenous (AV) fistula or graft in the arm and determined to be adequate for a chronic hemodialysis therapy.~5. AV fistula has already been demonstrated to adequately permit one or more hemodialysis sessions.~6. Subject prescribed blood flow rates between 200 ml/min and 450 ml/min~7. In women with child-bearing potential, negative urine or serum pregnancy test at Screening.~8. Subject able to communicate effectively with investigative staff, competent and willing to give written informed consent, and able to comply with entire study procedures.~9. Hemoglobin ≥9 g/dL (consistent with KDOQI guidelines)~10. Normal platelet count (≥150,000 /mm3)~11. International Normalized Ratio (INR) ≤ 1.5~Exclusion Criteria:~1. Subjects receiving chronic hemodialysis with a vascular catheter.~2. Subjects with vascular access that is determined by the clinician to be unacceptable for a hemodialysis procedure.~3. Patients with a bleeding diathesis~4. Patients receiving anti-coagulants~5. Previous vascular access surgery (≤30 days from study entry) or planned access surgery~6. Known hypersensitivity to any imaging agents (e.g., contrast) that may be required during the study period~7. Patients with confirmed vasculitis~8. Vascular access infection or systemic active infection within 30 days of study entry~9. Life expectancy less than 12 months~10. Planned renal transplantation or planned conversion to peritoneal dialysis~11. Subjects with any condition determined by the investigator that precludes them from safely participating in the study.

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard of Care vs. V Needle Performance Assessment (Type: EXPERIMENTAL): Subjects will undergo three dialysis sessions using standard of care needles (control) and results will be compare to 6 dialysis sessions using the V Needle (experimental).

Based on this trial design, predict the completion outcome and termination type (if applicable).